Foote, J. R., Liang, M. I., Secord, A. A., Jewell, E., Cohn, D. E., Rimel, B. J., & Havrilesky, L. J. (2017). Prospective patient-elicited value assessments of options in the primary treatment of ovarian cancer. In Gynecologic Oncology (Vol. 145, pp. 45–46). Elsevier BV. https://doi.org/10.1016/j.ygyno.2017.03.115

Foote, J. R., M. I. Liang, A. A. Secord, E. Jewell, D. E. Cohn, B. J. Rimel, and L. J. Havrilesky. “Prospective patient-elicited value assessments of options in the primary treatment of ovarian cancer.” In Gynecologic Oncology, 145:45–46. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.03.115.

Foote JR, Liang MI, Secord AA, Jewell E, Cohn DE, Rimel BJ, et al. Prospective patient-elicited value assessments of options in the primary treatment of ovarian cancer. In: Gynecologic Oncology. Elsevier BV; 2017. p. 45–6.

Foote, J. R., et al. “Prospective patient-elicited value assessments of options in the primary treatment of ovarian cancer.” Gynecologic Oncology, vol. 145, Elsevier BV, 2017, pp. 45–46. Crossref, doi:10.1016/j.ygyno.2017.03.115.

Foote JR, Liang MI, Secord AA, Jewell E, Cohn DE, Rimel BJ, Havrilesky LJ. Prospective patient-elicited value assessments of options in the primary treatment of ovarian cancer. Gynecologic Oncology. Elsevier BV; 2017. p. 45–46.